Podcast Episodes
Back to Search291: The plight of the VC, Gilead's latest setback, & more M&A
We discuss how biotech's downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a…
2 years, 9 months ago
290: Biotech layoffs, slumping stocks, and a 2024 preview
Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies …
2 years, 9 months ago
289: Live! From #JPM24
Recording from the STAT co-working space outside the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshin…
2 years, 9 months ago
287: 2023 in review, CEO report cards, and a look at the year ahead
It's our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some rea…
2 years, 10 months ago
286: FTC v. biotech, Pfizer's kitchen sink, & Vertex's future
First, we delve into the fallout over the FTC's move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surpris…
2 years, 10 months ago
285: CRISPR history, biotech struggles, & a big week for deals
With the first CRISPR-based medicine expected to win FDA approval any minute now, STAT’s Megan Molteni joins us to discuss how we got here and what i…
2 years, 10 months ago
284: AbbVie’s big deal, CAR-T’s risks, & getting a biotech job
We discuss why AbbVie is spending $10 billion on a cancer-focused company that spent four decades on the path to its first FDA approval, a deal with …
2 years, 10 months ago
283: A CRISPR milestone, algorithms amok, & biotech mixology
Our colleague Casey Ross joins us to tell the bombshell story of how the nation's largest health insurer used a computer algorithm to deny patient ca…
2 years, 11 months ago
From Tradeoffs: Can the U.S. put an end to surprise ambulance bills?
From our reporting partners at Tradeoffs: Congress banned most surprise medical bills back in 2020, with one major exception: ambulance rides. Most p…
2 years, 11 months ago
From Tradeoffs: Can the U.S. Put an End to Surprise Ambulance Bills?
From our reporting partners at Tradeoffs: Congress banned most surprise medical bills back in 2020, with one major exception: ambulance rides. Most p…
2 years, 11 months ago